세계 헬스케어 컨설팅 서비스 시장 - 규모, 점유율, 동향 분석 보고서 : 서비스별, 최종 용도별, 지역별 부문 예측(2024-2030년)

Healthcare Consulting Services Market Growth & Trends:

The global healthcare consulting services market size is expected to reach USD 51.98 billion by 2030 and register a CAGR of 9.33% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing budget cuts, the desire to enhance operational efficiency, changing healthcare policies and regulations, and growing demand to implement new technologies such as big data analytics, cloud deployment, and IoT among healthcare institutions such as life sciences companies and government bodies are some of the key factors driving the healthcare consulting services market.

Healthcare consulting services firms assist healthcare organizations in increasing their efficiency and profits; they also assist in providing structural recommendations for the firm. These advantages associated with healthcare consulting are expected to improve demand for these services across the forecast period. Over the years, there has been uncertainty over healthcare reform, growth in employer self-insurance, a rise in patient pay responsibility, and a growing demand for understanding healthcare coverage. These issues are likely to improve the demand for healthcare consulting services for managing payers' needs.

Pharmaceutical companies are heavily investing in the research and development of new drugs. As a result, the number of new drugs in the pipeline has increased in recent years. According to the Pharma R&D annual review, as of 2022, over 20,109 drugs were in the pipeline. These drugs are expected to be launched in the coming years. Due to the uncertainties created by the COVID-19 pandemic, pharmaceutical companies are expected to collaborate with strategic consultants to develop their launch strategy. This is expected to support market growth in the post-pandemic period.

Healthcare Consulting Services Market Report Highlights:

• The strategic management consulting segment accounted for 42.39% of the global revenue in 2023. The growing number of mergers and acquisitions among healthcare organizations such as pharmaceutical companies, biotechnology companies, and others is one of the major factors supporting the demand for strategic management consulting services.
• The pharmaceutical and biotechnology companies segment dominated the market in 2023 and it is also expected to witness the fastest growth over the forecast period.
• North America dominated the market and accounted for a 38.14% share in 2023. This can be attributed to the increased adoption of digital solutions by healthcare organizations such as public agencies, pharmaceutical companies, biotechnology companies' hospitals, and other institutions.
• Asia Pacific is anticipated to witness the fastest growth in the market. Increasing regional expansions in business by the health care organizations across region and the presence of a significant number of consultants are some key factors supporting market growth in Asia-Pacific.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Services
  • 1.2.2. End-use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Services outlook
  • 2.2.2. End-use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Healthcare Consulting Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing pressure to reduce costs in the healthcare settings.
    • 3.2.1.2. Increasing demand for digitalization
    • 3.2.1.3. Changing regulatory framework contributing to the demand for consulting services
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Intellectual Property Issues
• 3.3. Healthcare Consulting Services Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. Pricing Analysis

Chapter 4. Healthcare Consulting Services Market: Services Estimates & Trend Analysis

• 4.1. Services Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Healthcare Consulting Services Market by Services Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Strategic Management Consulting
    • 4.4.1.1. Strategic Management Consulting Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Financial Management Consulting
    • 4.4.2.1. Financial Management Consulting Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Information Technology Consulting
    • 4.4.3.1. Information Technology Consulting Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Human Resource Consulting
    • 4.4.4.1. Human Resource Consulting Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Healthcare Consulting Services Market: End-use Estimates & Trend Analysis

• 5.1. End-use Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Healthcare Consulting Services Market by End-use Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Pharmaceutical and Biotechnology Companies
    • 5.4.1.1. Pharmaceutical and Biotechnology Companies Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Hospitals
    • 5.4.2.1. Hospitals Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Healthcare Payers
    • 5.4.3.1. Healthcare Payers Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Other Healthcare Providers
    • 5.4.4.1. Other Healthcare Providers Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Healthcare Consulting Services Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2023 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.6. Norway
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.8. Denmark
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.2. Mexico
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Regulatory framework
    • 6.9.1.3. Competitive scenario
    • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2023
  • 7.3.4. Accenture
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Services benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. McKinsey & Company
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Services benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Deloitte Global
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Services benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. L.E.K. Consulting
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Services benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. PwC
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Services benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Huron Consulting Group Inc. and affiliates.
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Services benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Cognizant
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Services benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. EY
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Services benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Bain & Company, Inc.
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Services benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. IQVIA Inc,
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Services benchmarking
    • 7.3.13.4. Strategic initiatives
  • 7.3.14. Boston Consulting Group
    • 7.3.14.1. Company overview
    • 7.3.14.2. Financial performance
    • 7.3.14.3. Services benchmarking
    • 7.3.14.4. Strategic initiatives